Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats.

Abstract

Male and female, arteriosclerotic and non-arteriosclerotic rats were treated with the anti-lipemic agent, clofibrate, for 8 days and then subjected to an acute myocardial infarction by injecting them with two large doses of isoproterenol spaced 24 hours apart. The animals were killed at sequential time intervals during the acute necrosis and early repair phases of myocardial infarction. Pre-treatment with clofibrate caused a definite improvement in survival, less shock and prostration, and ECG evidence of little or no ischemia. Increased SGOT levels, hepatic lipid and necrosis were indicative of advanced liver damage. Although clofibrate-treated animals showed little change in serum lipids during the acute cardiac necrosis phase, they were hyperglycemic and showed the greatest increase in BUN levels. Clofibrate-treated animals had higher serum corticosterone levels than those given isoproterenol alone. Despite superior survival rates, both the arteriosclerotic and non-arteriosclerotic, clofibrate-treated animals exhibited equally severe histopathologic evidence of myocardial damage. It is suggested that the protective effect of prophylactic treatment with clofibrate against isoproterenol-induced myocardial infarction in rats may be due to its ability to change corticosterone levels in the circulation.

• Authors: B C Wexler, B P Greenberg
• Journal: Atherosclerosis (Atherosclerosis) Vol. 29 Issue 3 Pg. 373-95 (Mar 1978) ISSN: 0021-9150 [Print] Ireland
• PMID: 666886 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Blood Glucose
• Lipids
• L-Lactate Dehydrogenase
• Aspartate Aminotransferases
• Alanine Transaminase
• Creatine Kinase
• Clofibrate
• Isoproterenol
• Corticosterone

Topics

• Alanine Transaminase (blood)
• Animals
• Aspartate Aminotransferases (blood)
• Blood Glucose (analysis)
• Blood Urea Nitrogen
• Clofibrate (metabolism, therapeutic use)
• Coronary Disease (complications)
• Coronary Vessels (pathology)
• Corticosterone (blood)
• Creatine Kinase (blood)
• Female
• Isoproterenol (adverse effects)
• L-Lactate Dehydrogenase (blood)
• Lipids (blood)
• Male
• Myocardial Infarction (chemically induced, mortality, pathology)
• Myocardium (pathology)
• Necrosis
• Rats